Navigation Links
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
Date:11/1/2007

fm?eventid=45704" target="_new">http://ir.unither.com/eventdetail.cfm?eventid=45704.

About United Therapeutics

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life- threatening cardiovascular, cancer and infectious diseases.

About Lung Rx

Lung Rx is a biotechnology company focused on unmet medical needs in pulmonary medicine and pulmonary delivery of innovative therapeutic products.

Forward-looking Statements

Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Reform Act of 1995. Forward-looking statements include our expectation regarding the pursuit of regulatory approvals for Viveta, our expectation that Viveta will be co-promoted in the United States by United Therapeutics' commercialization group and Lung Rx's pulmonary division, and our expectation that full data from the trial will be presented at an upcoming medical meeting and will also be available in peer-reviewed journal articles. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, which could cause actual results to differ materially from anticipated results. These risks and uncertainties include, among others, the failure of Viveta and the nebulizers used to administer Viveta to receive regulatory approvals on the schedule expected; the uncertainties of launching a new product on a global scale following receipt of regulatory approvals, if received, due to misestimates of the time and resources required to do so, or for other reasons; the failure of Viveta to receive favorable pricing or reimbursement approvals; the possible inaccuracies of our analysis with respect to the TRIUMPH-1 preliminary trial results and market opportunity; and our or
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Man against HIV – new vaccine ready for human trials
2. FDA approves Phase 0 trial which tests experimental drugs on humans
3. Male contraceptive in trial
4. How do patients benefit of clinical trials
5. Glenmark’s new molecule to go through trial
6. Clinical trials need to be more frank
7. First head-to-head trials of once weekly Fosamax and Actonel therapies
8. Hormone Replacement Therapy increases the risk of endometrial cancer
9. Atrial fibrillation predicts for acute ischaemic stroke
10. Spray on contraceptive clears Phase I trial
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... Indosoft Inc , developers of Q-Suite, ... pleased to announce the development of Q-Suite 5.9. Building ... of Q-Suite, this new version will include enhancements to ... features to the leading edge call center software. General ... add features to enhance security and protection. Administrators will ...
(Date:2/28/2015)... The Mesothelioma Applied Research Foundation (Meso ... Symposium on Malignant Mesothelioma on Monday, March 2. The ... Bethesda in Bethesda, Maryland. The following award recipients will ... the mission to cure mesothelioma. , The Klaus Brauch ... Miriam Ratner. Miriam runs the Meso Foundation’s monthly spousal ...
(Date:2/28/2015)... Beach, CA (PRWEB) February 28, 2015 ... needs of Central Coast area residents, recently announced a ... System. It’s a treatment option for new and ... kick off 2015 with a bright, white smile, Dr. ... discounted price of $299, marked down from the regular ...
(Date:2/28/2015)... Flagstaff, AZ (PRWEB) February 28, 2015 ... drug and alcohol treatment center , and current student ... State University, has implemented a weekly forum in psychoeducation ... high school in Flagstaff, AZ as part of her ... a big need for support and counseling at the ...
(Date:2/28/2015)... 2015 The noted Friedman Dental Group ... have officially relaunched their website. The new version of ... contains a new section about their team members. Potential ... full biographies of each Friedman Dental Group team member ... was designed to provide our patients with the opportunity ...
Breaking Medicine News(10 mins):Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Friedman Dental Group Announces Their Updated Website 2
... of LDL-cholesterol by almost ten per cent, says a ... this could offer the possibility of formulating an additional ... to be seen since the reductions were not as ... the ingredients. ,High cholesterol levels, hypercholesterolaemia, ...
... are calling on the Federal Government to fund a new ... ,Rotavirus puts 10,000 Australian children in hospital each year, ... at doctors' surgeries with symptoms of acute diarrhoea and vomiting. ... aged six to 32 weeks, is only available by private ...
... Champaign-Urbana have found that people employed in chimpanzee-focused research ... exchanging gastrointestinal bacteria – specifically Escherichia coli – with ... strains migrating to chimps are resistant to antibiotics used ... found bacterial exchanges between humans and non-human primates – ...
... the Journal of Clinical Oncology reveals there may be ... patients// with recurrent prostate cancer. ,This something ... scientists at Cedars-Sinai Medical Center in Los Angeles say ... cancer patients with no previous chemotherapy treatment. ...
... health units is well below the real number of infections, ... in Maputo, at the opening of a national meeting on ... detect about 50 per cent of people suffering from tuberculosis". ... were notified, which was an increase of five per cent ...
... chances of colorectal cancers getting missed out in patients ... than a gastroenterologist// or a surgeon. This was disclosed ... Canadian researchers. ,This study was conducted on ... Western Ontario along with her team. According to this ...
Cached Medicine News:Health News:Combined Ingredients may Cut Cholesterol Levels 2Health News:Combined Ingredients may Cut Cholesterol Levels 3Health News:Call for Rotavirus Vaccine Funding 2Health News:E. Coli Bacteria Migrating Between Humans, Chimps 2Health News:E. Coli Bacteria Migrating Between Humans, Chimps 3Health News:Mozambique: Half of Tuberculosis Cases Go Undiagnosed 2Health News:Mozambique: Half of Tuberculosis Cases Go Undiagnosed 3
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... a pre-clinical study published in the Proceedings ... www.pnas.org/cgi/doi/10.1073/pnas.1500712112 ) that showed when ibrutinib (IMBRUVICA ® ... checkpoint inhibitor), suppression of tumor growth was enhanced ... treating certain hematologic cancers and solid tumors with ...
(Date:2/27/2015)... , Feb. 27, 2015  Following a ... Committee that moved H.R. 284, the Medicare DMEPOS ... American Association for Homecare (AAHomecare) released a statement ... action to pass the legislation. "Today,s ... the House Ways and Means Committee is a ...
(Date:2/27/2015)... , Feb. 27, 2015 Securities lawyers ... board of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ... per share. Concerned SLXP investors are encouraged to contact ... The investigation focuses upon the shareholder value ... Salix shareholders would receive only $158.00 per share in ...
Breaking Medicine Technology:In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2
... 2012  American Capital, Ltd. (Nasdaq: ACAS ) ... million together with its affiliates, in the debt and ... device company focused on women,s health.   "American ... Halt Medical as it continues to grow its medical ...
... announces that a new market research report is ... Global Ophthalmic Lasers Industry ... The global outlook series on Ophthalmic Lasers ... and concise summaries of research findings. Illustrated with ...
Cached Medicine Technology:American Capital and its Affiliates Invest $20 Million in Portfolio Company Halt Medical 2Global Ophthalmic Lasers Industry 2Global Ophthalmic Lasers Industry 3Global Ophthalmic Lasers Industry 4Global Ophthalmic Lasers Industry 5
... maximum impact for the marketing of optical ... displaying frames allows your retail area to ... and eye-catching displays. The products are shown ... motivated. Removable holders. Variable number of frames ...
Single Eyevee 2.0 Frame Clip. Available in black, clear and silver colors....
... ClinicDB is a multi-page ... that maintains a database of ... microscopy results, adverse reactions, etc. ... reports, letters and invoices that ...
Hoya Vision Care is focused on providing the best available most technically advanced and highest quality eye care products and services to the dispensing optometrist, ophthalmologist and optician....
Medicine Products: